Join a Study

This phase 1 clinical study is evaluating the safety and efficacy of the study medication, DONQ52.

This medication is designed to target an immune complex known to cause celiac disease symptoms. This may protect the small intestine of a person with celiac disease.

There is no gluten challenge in this study. You may be compensated for time and travel.

Requirements:

• You are 18-65 years old
• You have celiac disease
• You are already on a gluten-free diet
• You have had a diagnostic biopsy
• Other requirements will apply.

If you’re interested in the study, think you may qualify, or want to find a study site location near you, visit www.celiacdiseasestudy.com.

The goal of this virtual study is to better understand the symptoms and impacts of celiac disease.

There are no blood draws, gluten challenges, medications, or doctor visits required. Participants will complete daily questionnaires about their symptoms and life with celiac disease for 3 months—all from an online app! Compensation available.

You or Your Child Must Be

• 12 years or older*
• Diagnosed with celiac disease for 1+ years
• On a gluten-free diet for past 6+ months
• Experiencing celiac disease symptoms
• Living in the U.S.

*Parental permission for adolescents 12-17 required.

Learn More: virtualstudy.celiac.org

The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015.

In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.

NO gluten challenge

Requirements:

• 18-70 years old
• Biopsy-confirmed celiac disease
• On a gluten-free diet for at least the last 12 months
• Still experiencing celiac disease symptoms

Learn more at proactiveceliac.com
Use referral code: REFCDF

Solutions for Celiac is a non-invasive research study for those with celiac disease. It involves a powder that is mixed with water and consumed with a meal. The study medication is designed to reduce symptoms of accidental gluten exposure while on a gluten-free diet.

Previous clinical trials involving this investigational treatment showed reduced damage to the intestine and reduced symptoms after a gluten challenge (compared to placebo).

Up to $1300 in compensation, plus qualified travel reimbursement. Contact us for more information: [email protected]

Learn More: SolutionsforCeliac.com